Literature DB >> 28623776

Case series of patients treated with the oral fluoropyrimidine S-1 after capecitabine-induced coronary artery vasospasm.

Johannes J M Kwakman1, Arnold Baars2, Annette A van Zweeden3, Pieter de Mol4, Miriam Koopman5, Wouter E M Kok6, Cornelis J A Punt7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28623776     DOI： 10.1016/j.ejca.2017.05.022

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  5 in total

1.  Myocardial Ischemia Induced by 5-Fluorouracil: A Prospective Electrocardiographic and Cardiac Biomarker Study.

Authors:  Merete Vaage-Nilsen; Dorte L Nielsen; Anne Dyhl-Polk; Morten Schou; Kirsten K Vistisen; Anne-Sophie Sillesen; Eva Serup-Hansen; Jens Faber; Tobias W Klausen; Stig E Bojesen
Journal:  Oncologist       Date:  2020-10-07

2.  The Incidence, Risk Factors, and Outcomes With 5-Fluorouracil-Associated Coronary Vasospasm.

Authors:  Amna Zafar; Zsofia D Drobni; Ramya Mosarla; Raza M Alvi; Matthew Lei; Uvette Y Lou; Vineet K Raghu; Sean P Murphy; Maeve Jones-O'Connor; Sarah Hartmann; Hannah K Gilman; Colin D Weekes; John R Clark; Jeffrey Clark; Lawrence Blaszkowsky; Erica Tavares; Tomas G Neilan
Journal:  JACC CardioOncol       Date:  2021-03-16

Review 3.  Fluoropyrimidine-induced cardiotoxicity.

Authors:  Andrada Larisa Deac; Claudia Cristina Burz; Ioana Corina Bocsan; Anca Dana Buzoianu
Journal:  World J Clin Oncol       Date:  2020-12-24

4.  The efficacy and safety of cardio-protective therapy in patients with 5-FU (Fluorouracil)-associated coronary vasospasm.

Authors:  Amna Zafar; Zsofia D Drobni; Matthew Lei; Carlos A Gongora; Thiago Quinaglia; Uvette Y Lou; Ramya Mosarla; Sean P Murphy; Maeve Jones-O'Connor; Ali Mahmood; Sarah Hartmann; Hannah K Gilman; Colin D Weekes; Ryan Nipp; John R Clark; Jeffrey W Clark; Lawrence S Blaszkowsky; Erica Tavares; Tomas G Neilan
Journal:  PLoS One       Date:  2022-04-07       Impact factor: 3.752

5.  Continuation of fluoropyrimidine treatment with S-1 after cardiotoxicity on capecitabine- or 5-fluorouracil-based therapy in patients with solid tumours: a multicentre retrospective observational cohort study.

Authors:  P Osterlund; S Kinos; P Pfeiffer; T Salminen; J J M Kwakman; J-E Frödin; C H Shah; H Sorbye; R Ristamäki; P Halonen; L M Soveri; E Heervä; A Ålgars; M Bärlund; H Hagman; R McDermott; M O'Reilly; R Röckert; G Liposits; R Kallio; P Flygare; A J Teske; E van Werkhoven; C J A Punt; B Glimelius
Journal:  ESMO Open       Date:  2022-03-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.